Ajanta Pharma gets 2 procedural observation from USFDA for Dahej unit

12 Sep 2022 Evaluate

United States Food and Drug Administration (USFDA) has issued Form 483 with 2 procedural observations to Ajanta Pharma’s formulation facility at Dahej in Gujarat. USFDA has conducted inspection at Dahej unit from September 05, 2022 to September 09, 2022. The company is in the process of responding to the same within the stipulated time prescribed by USFDA.

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×